REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Living with transfusion-dependent BT may feel like a lot.
Managing your anemia associated with transfusion-dependent BT may make your treatment feel complicated. REBLOZYL may help reduce the number of transfusions you need to treat your anemia.
You may have questions about your anemia or how REBLOZYL can help, like:
How does anemia
in BT happen?
What is
REBLOZYL?
Why choose
REBLOZYL?
Where can I find
resources and assistance?